Αποτελέσματα Αναζήτησης
The study found that significantly more participants treated with erenumab than those treated with placebo had a 50% reduction in migraine days. The primary endpoint for this study was the mean change from baseline in the number of monthly migraines over the 3-month treatment period.
10 Οκτ 2022 · It discusses the international guidelines on drug treatment for chronic migraine and evaluates non-drug treatments including behavioral and complementary therapies and lifestyle modifications.
15 Ιουν 2021 · In this systematic review, the benefits and harms associated with acute treatments for episodic migraine were assessed, including pharmacologic and nonpharmacologic therapies. This review focused on pain-related outcomes, such as pain relief and pain freedom, as well as function and adverse events. Methods.
18 Ιουν 2021 · Further, we outline best practices for acute and preventive treatment of migraine in various patient populations, including adults, children and adolescents, pregnant and breastfeeding women,...
Objectives: To summarize the baseline methods for the Migraine in America Symptoms and Treatment (MAST) Study and evaluate gender differences in sociodemographics and headache features; consultation and diagnosis patterns; and patterns of acute and preventive treatment use for migraine among study participants.
17 Αυγ 2021 · The treatment of acute migraine is nuanced, as specific therapy is largely dependent on individual factors such as patient preference, headache characteristics, associated symptoms, convenience, and cost. This chapter discusses the pharmacologic options and their associated evidence in the management of acute migraines.
Migraine Headache Sample Case Studies. Sample Case History: Severe Migraine with Mild Chronic Daily Headache. prolonged 2 to 3 day migraines twice per month. S. e also has mild chronic tension headache (CDH). Sh. has difficulty sleeping and is mildly anxious. .
